Lingzhi demonstrates potent antitumor effects in EGFR-mutated NSCLC by downregulating EGFR expression, inhibiting key oncogenic pathways (PI3K/AKT/mTOR, ERK, Wnt/β-catenin), and suppressing EMT and angiogenesis. Here, EGFR is linked to non-small cell lung carcinoma.